20170220-三星证券-Samsung_Healthcare_Weekly_16页_989kb
报告摘要
Samsung Healthcare Weekly Summary
Core Content Overview
This document provides a comprehensive update on the global healthcare sector, focusing on the performance of various indices, forward P/E ratios, P/B ratios, and share price movements of major healthcare companies in South Korea and globally. It is authored by Samsung Securities analysts, including Brian Lee (Team Head), SunYoung Yoon, Kevin Kim, and Wonyong Park (Research Associate).
Key Indices and Performance
Global Healthcare Indices
| Country | Index | Forward P/E (x) | Portion of Market Cap (%) | 1-week (%) | 1-month (%) | 3-month (%) | YTD (%) |
|---|---|---|---|---|---|---|---|
| Korea | KRX Health Care | 34.9 | 5.1 | 2.8 | 0.5 | (3.9) | (2.5) |
| Korea | Kospi Medical Supplies | 44.3 | 2.2 | 4.1 | 2.9 | (2.9) | 0.9 |
| Korea | Kosdaq Pharmaceuticals | 27.6 | 2.2 | 1.0 | 0.1 | (3.6) | (3.8) |
| Korea | Kosdaq Medical and Precision Machines | 17.5 | 0.5 | (0.6) | (2.7) | (5.7) | (4.1) |
| US | S&P 500 Healthcare | 15.7 | 8.3 | 2.5 | 5.4 | 5.8 | 6.7 |
| US | S&P 500 Pharma/Biotech | 15.1 | 5.1 | 3.1 | 6.1 | 5.2 | 6.1 |
| US | Nasdaq Biotechnology | 39.6 | 2.4 | 3.5 | 7.7 | 3.4 | 11.1 |
| US | S&P 500 Healthcare Equipment and Services | 16.9 | 3.2 | 1.6 | 4.1 | 6.8 | 7.7 |
| Europe | MSCI Europe Healthcare | 16.0 | 11.5 | 1.5 | 6.1 | 8.8 | 4.5 |
| Europe | MSCI Europe Pharm/Bio | 15.6 | 10.0 | 1.7 | 6.8 | 8.9 | 5.0 |
| Europe | MSCI Europe Healthcare Equipment and Services | 21.1 | 1.5 | (0.2) | 0.3 | 8.2 | 0.2 |
| Japan | MSCI Japan Healthcare | 25.4 | 7.2 | (0.8) | 1.8 | 3.7 | 0.3 |
| Japan | MSCI Japan Pharm/Bio | 25.3 | 5.3 | (0.6) | 3.0 | 3.7 | 1.4 |
| Japan | Topix Pharma | 25.0 | 4.8 | (0.4) | 2.8 | 4.0 | 1.4 |
| Japan | MSCI Japan Healthcare Equipment and Services | 25.6 | 1.9 | (1.1) | (1.1) | 3.5 | (2.3) |
| China | MSCI China Healthcare | 17.9 | 1.6 | (1.4) | 1.6 | 5.8 | 9.3 |
| India | MSCI India Healthcare | 24.9 | 7.7 | 1.8 | 3.3 | (0.5) | 3.7 |
Key Performance Notes
- The KRX Health Care index has a forward P/E of 34.9 and a market cap portion of 5.1%.
- The Kospi Medical Supplies index has a higher forward P/E of 44.3, with a 4.1% performance over the last month.
- The Kosdaq Pharmaceuticals index has a lower forward P/E of 27.6 and a market cap portion of 2.2%.
- The Nasdaq Biotechnology index shows a strong performance with a 3.5% gain over 3 months and a 11.1% YTD increase.
- The MSCI Europe Healthcare Equipment and Services index has a lower performance, with a 0.2% decline over 3 months.
- The MSCI Japan Healthcare Equipment and Services index shows a negative performance of 1.1% over 3 months and 2.3% YTD decline.
Major Korean Healthcare Firms
Pharmaceutical Holdings
- Hanmi Science: Market cap of 3,917 KRWb, share price of 62,900 KRW, P/E of 41.3 (2015) and n/a (2016E).
- Green Cross Holdings: Market cap of 1,256 KRWb, share price of 25,500 KRW, P/E of 30.7 (2015) and n/a (2016E).
- Donga Socio Holdings: Market cap of 808 KRWb, share price of 133,500 KRW, P/E of 16.9 (2015) and 5.5 (2016E).
- Daewoong: Market cap of 599 KRWb, share price of 51,500 KRW, P/E of 17.0 (2015) and 52.6 (2016E).
- JW Holdings: Market cap of 507 KRWb, share price of 8,270 KRW, P/E of 4072.0 (2015) and 4.7 (2016E).
- Chongkundang Holdings: Market cap of 314 KRWb, share price of 62,700 KRW, P/E of 30.4 (2015) and 48.6 (2016E).
Pharmaceuticals
- Hanmi Pharm: Market cap of 3,500 KRWb, share price of 313,500 KRW, P/E of 48.2 (2015) and 36.0 (2016E).
- Yuhan: Market cap of 2,518 KRWb, share price of 212,500 KRW, P/E of 24.6 (2015) and 19.3 (2016E).
- Green Cross: Market cap of 1,718 KRWb, share price of 147,000 KRW, P/E of 22.5 (2015) and 30.3 (2016E).
- SK Chemicals: Market cap of 1,530 KRWb, share price of 60,000 KRW, P/E of 31.7 (2015) and 13.5 (2016E).
- Young Jin Pharm: Market cap of 1,368 KRWb, share price of 7,480 KRW, P/E of 111.7 (2015) and n/a (2016E).
- Chong Kun Dang: Market cap of 1,049 KRWb, share price of 111,500 KRW, P/E of n/a (2015) and 23.0 (2016E).
APIs
- Kolon Life Science: Market cap of 849 KRWb, share price of 111,500 KRW, P/E of 1659.9 (2015) and 127.2 (2016E).
- ST Pharm: Market cap of 802 KRWb, share price of 43,400 KRW, P/E of n/a (2015) and 13.4 (2016E).
- Kyongbo Pharmaceutical: Market cap of 322 KRWb, share price of 13,450 KRW, P/E of 12.4 (2015) and 21.6 (2016E).
- Daebongs: Market cap of 137 KRWb, share price of 12,400 KRW, P/E of 15.5 (2015) and 13.7 (2016E).
- CKD Bio: Market cap of 123 KRWb, share price of 23,450 KRW, P/E of 21.7 (2015) and 10.8 (2016E).
- Estech Pharma: Market cap of 119 KRWb, share price of 10,400 KRW, P/E of n/a (2015) and n/a (2016E).
- Bukwang Pharmaceutical: Market cap of 1041 KRWb, share price of 23,350 KRW, P/E of 34.5 (2015) and 61.2 (2016E).
- Daewoong Pharm: Market cap of 977 KRWb, share price of 84,300 KRW, P/E of 19.2 (2015) and n/a (2016E).
- JW Pharmaceutical: Market cap of 920 KRWb, share price of 47,750 KRW, P/E of 304.5 (2015) and 68.4 (2016E).
- Donga ST: Market cap of 813 KRWb, share price of 96,300 KRW, P/E of 23.8 (2015) and 31.9 (2016E).
- Kwang Dong Pharm: Market cap of 475 KRWb, share price of 9,060 KRW, P/E of 16.7 (2015) and 13.3 (2016E).
- Boryung Pharm: Market cap of 450 KRWb, share price of 32,350 KRW, P/E of 12.0 (2015) and 14.0 (2016E).
- Daewon Pharmaceutical: Market cap of 373 KRWb, share price of 20,500 KRW, P/E of 17.1 (2015) and 16.7 (2016E).
- Huons: Market cap of 326 KRWb, share price of 52,700 KRW, P/E of n/a (2015) and n/a (2016E).
- Handok: Market cap of 294 KRWb, share price of 23,350 KRW, P/E of n/a (2015) and n/a (2016E).
- Korea United Pharm: Market cap of 290 KRWb, share price of 17,900 KRW, P/E of 13.0 (2015) and 15.9 (2016E).
- Whan In Pharm: Market cap of 267 KRWb, share price of 14,350 KRW, P/E of 17.7 (2015) and 14.3 (2016E).
Medical Devices
- Osstem Implant: Market cap of 896 KRWb, share price of 62,700 KRW, P/E of 55.7 (2015) and 33.9 (2016E).
- Viewworks: Market cap of 654 KRWb, share price of 65,400 KRW, P/E of 28.0 (2015) and 33.1 (2016E).
- Dio: Market cap of 452 KRWb, share price of 29,800 KRW, P/E of 45.1 (2015) and 24.4 (2016E).
- Value Added Technology: Market cap of 451 KRWb, share price of 30,350 KRW, P/E of 27.6 (2015) and 20.6 (2016E).
- Interjo: Market cap of 398 KRWb, share price of 36,950 KRW, P/E of 32.5 (2015) and 21.0 (2016E).
- Lutronic: Market cap of 392 KRWb, share price of 31,150 KRW, P/E of 82.3 (2015) and 36.5 (2016E).
- InBody: Market cap of 321 KRWb, share price of 23,450 KRW, P/E of 45.9 (2015) and 20.3 (2016E).
- Rayence: Market cap of 314 KRWb, share price of 18,900 KRW, P/E of n/a (2015) and 24.0 (2016E).
- JVM: Market cap of 288 KRWb, share price of 45,500 KRW, P/E of 67.4 (2015) and 25.8 (2016E).
- Sewoon Medical: Market cap of 174 KRWb, share price of 3,980 KRW, P/E of 76.6 (2015) and 16.9 (2016E).
- Huvitz: Market cap of 172 KRWb, share price of 14,500 KRW, P/E of 26.8 (2015) and 16.8 (2016E).
- Hans Biomed: Market cap of 160 KRWb, share price of 16,200 KRW, P/E of 38.2 (2015) and 28.5 (2016E).
- Coretec: Market cap of 127 KRWb, share price of 13,000 KRW, P/E of n/a (2015) and 47.2 (2016E).
- Mediana: Market cap of 121 KRWb, share price of 13,950 KRW, P/E of 19.2 (2015) and 16.1 (2016E).
- U&I Corporation: Market cap of 104 KRWb, share price of 13,550 KRW, P/E of n/a (2015) and 56.9 (2016E).
- Meta Biomed: Market cap of 95 KRWb, share price of 4,350 KRW, P/E of 107.3 (2015) and 12.5 (2016E).
- Hironic: Market cap of 91 KRWb, share price of 6,490 KRW, P/E of 62.5 (2015) and n/a (2016E).
- CU Medical Systems: Market cap of 48 KRWb, share price of 3,320 KRW, P/E of 23.4 (2015) and n/a (2016E).
Telemedicine
- Infinit Healthcare: Market cap of 168 KRWb, share price of 6,900 KRW, P/E of 40.4 (2015) and n/a (2016E).
- UBCare: Market cap of 140 KRWb, share price of 3,465 KRW, P/E of 23.5 (2015) and n/a (2016E).
- BIT Computer: Market cap of 90 KRWb, share price of 5,430 KRW, P/E of 27.9 (2015) and n/a (2016E).
Major Global Healthcare Firms
| Sector | Company | Currency | Market Cap (USDm) | Share Price (local) | P/E (x) | P/B (x) | 1-week (%) | 1-month (%) | 3-month (%) | YTD (%) |
|---|---|---|---|---|---|---|---|---|---|---|
| US Biotech | Amgen | USD | 127,620 | 173 | 17.7 | 4.4 | 3.2 | 12.7 | 19.3 | |
| US Biotech | Celgene | USD | 94,258 | 121 | 53.6 | 15.9 | 4.8 | 20.4 | 6.6 | |
| US Biotech | Gilead Sciences | USD | 91,504 | 70 | 8.5 | 6.1 | 7.8 | 5.1 | 5.3 | |
| US Biotech | Allergan | USD | 82,758 | 247 | 191.5 | 18.5 | 1.0 | 12.8 | 15.3 | |
| US Biotech | Abbott | USD | 77,224 | 45 | 23.6 | 20.3 | 3.1 | 3.2 | 4.6 | |
| US Biotech | Biogen Idec | USD | 62,397 | 289 | 19.4 | 14.3 | 7.1 | 5.3 | 5.2 | |
| US Biotech | Baxter International | USD | 27,049 | 50 | 33.5 | 26.1 | 2.4 | 3.0 | 1.5 |
Key Insights
- The global healthcare sector shows mixed performance with some indices experiencing declines and others showing gains.
- The Nasdaq Biotechnology index leads with a strong 3-month performance of 3.5% and a YTD increase of 11.1%.
- The MSCI Europe Healthcare Equipment and Services index shows a 0.2% decline over 3 months and a 0.2% YTD drop.
- In South Korea, the Kospi Medical Supplies index has a notable 4.1% performance over the last month.
- JW Pharmaceutical and Amgen show strong performance in terms of share price and P/E ratios.
- Samsung Biologics is excluded from several indices, indicating its unique position in the market.
Notes
- All data is based on the close on February 17.
- The report is prepared without undue external influence and reflects the analysts' views.
- Performance metrics include weekly, monthly, quarterly, and year-to-date (YTD) changes.
展开完整摘要
试读结束,高清完整版pdf/doc/ppt,请点下载